References
- Thompson Drossman G, Talley N J. Identification of subgroups of functional gastrointestinal disorders. Gastroenterology Int 1991; 4: 145–60
- Talley N J, Philips S F. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108: 865–79
- Nyren O, Lindberg G, Lindstr M E. Economic costs of functional dyspepsia. Pharmaco Economics. Adis International. 1992; 3: 312–24
- Talley N J, Weaver A L, Zinsmeister A R. Onset and disappearance of gastrointestinal symptom and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165–77
- Barbara L, Camilleri M, Corinaldesi R. Definition and investigation of dyspepsia. Dig Dis Sci 1989; 34: 1272–6
- Talley N J, Colin-Jones D, Koch K L. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology Int 1991; 4: 145–60
- Veldhuyzen van Zanten S JO, Tytgat K MAJ, Jalali S. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of tastritis, non-ulcer dyspepsia and campylobacter-associated gastritis. J Clin Gastroenterol 1989; 11: 496–501
- Dobrilla G, Comberlato Steele A. Drug treatment of functional dyspepsia. A Meta-Analysis of Randomized Controlled Clinical Trials. J Clin Gastroenterol 1989; 11: 169–77
- Talley N J. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991; 26(S182)47–60
- Poynard T, Mory B, Levoir D. Randomized trials in patients with dyspepsia. Non-ulcer dyspepsia. Pathophysiology and therapeutic approaches, J P Galmiche, R Jian, M Mignon, et al. John Libbey, London 1991; 21: 227–38
- Morgan D, Kraft W, Bender M. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988; 95: 1178–84
- Lambert J, Dunn K, Borromeo M. Campylobacter pylori – A role in non-ulcer dyspepsia. Scand J Gastroenterol 1989; 24(S100)7–13
- Glupczynski Y, Burette A, Labbe M. Campylobacter pylori associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol 1988; 83: 365–72
- Loffeld R J, Potters H V, Stobberingh E. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double-blind placebo-controlled trial with colloidal bismuth sub-citrate. Gut 1989; 30: 1206–12
- Kang J Y, Tay H H, Wee A. Effect of colloidal bismuth subcitrate on symptoms and histology in non-ulcer dyspepsia. A double-blind placebo-controlled study. Gut 1990; 31: 476–80
- Patchett S, Beattie S, Leen E. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. Br Med J 1991; 303: 1238–40
- Goh K L, Parasakthi N, Peh S C. Helicobacter pylori infection and non-ulcer dyspepsia. The effect of bismuth sub-citrate. Scand J Gastroenterol 1991; 26: 1123–31
- Veldhuyzen van Zanten S JO. Quality of Life as outcome measures in randomized clinical trials. Controlled Clin Trials 1991; 12(4)234–42
- Veldhuyzen van Zanten S JO, Tytgat K MAJ, de Gara C J. A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia. Eur J Gastroenterol Hepatol 1991; 3: 463–8
- Nyrén O. Functional dyspepsia; is gastric acid and/or Helicobacter pylori infection involved in the ethiology?. Eur J Gastroenterol Hepatol 1992; 4: 608–14
- Johannessen T, Fjosne U, Kleveland P M. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327–36
- Kirschner B, Guyatt G H. A methodologic framework for assessing health indices. J Chron Dis 1985; 38: 27–30
- Guyatt G H, Veldhuyzen van Zanten S JO, Feeney D H. Measuring Quality of Life in clinical trials. A taxonomy and review. Can Med J Assoc 1989; 140: 1441–8
- Richter J E. Stress and psychologic and environmental factors in functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl 182)40–6
- Sjöden P O, Bates S, Nyren O. Continuous self-recording of epigastric pain with two rating scales: compliance, authenticity, reliability and sensitivity. J Behav Assess 1983; 5: 327–44
- Veldhuyzen van Zanten S JO, Pollak P T, Tytgat K MAJ. Can severity of symptoms be used as outcome measures in trials of non-ulcer dyspepsia and Helicobacter pylori?. J Clin Epidemiol 1993; 46: 273–9
- Nyrén O, Adami H O, Bates S. Absence of therapeutic benefit from anatacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43